Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan

This study aimed to develop the feasible and effective universal screening strategy of the notable SARS-CoV-2 variants by Sanger Sequencing Strategy and then practically applied it for mass screening in Hiroshima, Japan. A total of 734 samples from COVID-19 confirmed cases in Hiroshima were screened...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Ko, Takahashi, Kazuaki, Nagashima, Shintaro, E, Bunthen, Ouoba, Serge, Hussain, Md Razeen Ashraf, Akita, Tomoyuki, Sugiyama, Aya, Sakaguchi, Takemasa, Tahara, Hidetoshi, Ohge, Hiroki, Ohdan, Hideki, Kubo, Tatsuhiko, Ishikawa, Nobuhisa, Takafuta, Toshiro, Fujii, Yoshiki, Mimori, Michi, Okada, Fumie, Kishita, Eisaku, Ariyoshi, Kunie, Kuwabara, Masao, Tanaka, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844052/
https://www.ncbi.nlm.nih.gov/pubmed/35165301
http://dx.doi.org/10.1038/s41598-022-04952-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844052/
https://www.ncbi.nlm.nih.gov/pubmed/35165301
http://dx.doi.org/10.1038/s41598-022-04952-2

Ejemplares similares